Active substance
Tolfenamic acid.
Indications
Cattle:
- As an adjunct in the reduction of acute inflammation associated with respiratory diseases and as an adjunct in the treatment of acute mastitis.
Pigs:
- As an adjunct in the treatment of Postpartum Dysgalactia Syndrome (PDS).
Cats:
- As an adjunct in the treatment of upper respiratory disease in association with antimicrobial therapy, if appropriate.
Dogs:
- For the treatment of inflammatory and painful postoperative syndromes and for the reduction of postoperative pain.
Dosage and route of administration
Cattle: intramuscular (IM) or intravenous (IV) use. For use as an adjunct in the reduction of acute inflammation associated with respiratory disease: 2 mg/kg bodyweight, equivalent to 1 ml/20 kg bodyweight by intramuscular injection. Treatment may be repeated once after 48 hours. The maximum injected volume is 20 ml per injection site. For use as an adjunct in the treatment of acute mastitis: 4 mg/kg bodyweight, equivalent to 1 ml/10 kg bodyweight as a slowly single intravenous injection.
Pigs: intramuscular (IM) use. 2 mg/kg bodyweight, equivalent to 1 ml/20 kg
bodyweight as a single intramuscular injection. The maximum injected volume is
20 ml per injection site.
Cats: subcutaneous (SC) use. 4 mg/kg bodyweight, equivalent to 1 ml/10 kg bodyweight, given as a single injection and repeated once after 24 hours if required and depending upon clinical assessment.
Dogs:intramuscular (IM) or subcutaneous (SC) use. 4 mg/kg bodyweight, equivalent to 1 ml/10 kg bodyweight, given as a single injection and repeated once after 24 hours if required and depending upon clinical assessment.
Withdrawal period
Meat:
Cattle: IM 12 days / IV 4 days
Pigs: 16 days
Milk:
Cattle: IM 0 hours / IV 24 hours
Presentations
20, 50, 100 and 250 ml vials.
Registry no. 4125 ESP
